← Open Payments lookup

MARY PARKER: Open Payments

NPI 1962526434 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$509 in 33 payments from 10 companies in 2025. Trend: 2023 $576 · 2024 $616 · 2025 $509

Food & beverage: $509
CompanyPaymentsAmount
ABBVIE INC.17$201
Novo Nordisk Inc4$70
Dexcom, Inc.3$67
AstraZeneca Pharmaceuticals LP3$56
ABIOMED1$25
Astellas Pharma US Inc1$20
Lilly USA, LLC1$19
Lundbeck LLC1$18
Ardelyx, Inc.1$17
Abbott Laboratories1$16

Products named: QULIPTA, UBRELVY, Dexcom G6 Transmitter, AIRSUPRA, Ozempic, Wegovy, Veozah, MOUNJARO.

Industry payments across LA — which companies pay providers there.